8-K
filed June 10, 2026, 4:54 PM ET
ticker BIIB
CIK 0000875045
other material
confidence high
sentiment neutral
materiality 0.05
Biogen shareholders elect all 10 director nominees and ratify auditor at 2026 annual meeting
BIOGEN INC.
- All ten board nominees elected; highest vote against for Eric K. Rowinsky (28.2M against of 121.9M voted).
- PricewaterhouseCoopers ratified as auditor for FY2026 with 124.6M for, 6.6M against.
- Advisory say-on-pay approved with 114.2M for, 7.5M against, 9.4M broker non-votes.
- Meeting held June 9, 2026; results filed on Form 8-K.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BIOGEN INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-09 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BIOGEN INC. shareholders approved Advisory vote on executive compensation at the 2026-06-09 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
Stockholders approved the advisory vote on executive compensation
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BIOGEN INC. shareholders approved Election of Directors at the 2026-06-09 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
Stockholders elected ten nominees to the Board of Directors to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.